Literature DB >> 17855816

Survival and long-term functional outcome in 1,155 consecutive neurocritical care patients.

Gregor Broessner1, Raimund Helbok, Peter Lackner, Michael Mitterberger, Ronny Beer, Klaus Engelhardt, Christian Brenneis, Bettina Pfausler, Erich Schmutzhard.   

Abstract

OBJECTIVE: To analyze survival, mortality, and long-term functional disability outcome and to determine predictors of unfavorable outcome in critically ill patients admitted to a neurologic intensive care unit (neuro-ICU).
DESIGN: Retrospective cohort study with post-neuro-ICU health-related evaluation of functional long-term outcome.
SETTING: Ten-bed neuro-ICU in a tertiary care university hospital. PATIENTS: A consecutive cohort of 1,155 patients admitted to a neuro-ICU during a 36-month period.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: A total of 1,155 consecutive patients, of whom 41% were women, were enrolled in the study. The predominant reasons for neuro-ICU care were cerebrovascular diseases, such as intracerebral hemorrhage (20%), subarachnoid hemorrhage (16%), and complicated, malignant ischemic stroke (15%). A total of 213 patients (18%) died in the neuro-ICU. The Glasgow Outcome Scale and modified Rankin scale were dichotomized into two groups determining unfavorable vs. favorable outcome (Glasgow Outcome Scale scores 1-3 vs. 4-5 and modified Rankin scale scores 2-6 vs. 0-1). Factors associated with unfavorable outcome in the unselected cohort according to logistic regression analysis were admission diagnosis, age (p < .01), and a higher score in the simplified Therapeutic Intervention Scoring System (TISS-28) at time of admission (p < .01). Functional long-term outcome was evaluated by telephone interview for 662 patients after a median follow-up of approximately 2.5 yrs by evaluating modified Rankin scale and Glasgow Outcome Scale scores. Factors associated with unfavorable functional long-term outcome were admission diagnosis, sex, age of >70 yrs (odds ratio, 8.45; 95% confidence interval, 4.52-15.83; p < .01), TISS-28 of >40 points at admission (odds ratio, 4.05; 95% confidence interval, 2.54-6.44; p < .01), TISS-28 of >40 points at discharge from the neuro-ICU (odds ratio, 3.50; 95% confidence interval, 1.51-8.09; p < .01), and length of stay (odds ratio, 1.01; 95% confidence interval, 1.00-1.03; p = .02).
CONCLUSION: We found admission diagnosis, age, length of stay, and TISS-28 scores at admission and discharge to be independent predictors of unfavorable long-term outcome in an unselected neurocritical care population.

Entities:  

Mesh:

Year:  2007        PMID: 17855816     DOI: 10.1097/01.ccm.0000281449.07719.2b

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  24 in total

1.  [Indications and outcome of ventilated patients treated in a neurological intensive care unit].

Authors:  D Steffling; M Ritzka; W Jakob; A Steinbrecher; S Schwab-Malek; B Kaiser; P Hau; S Boy; K Fuchs; U Bogdahn; F Schlachetzki
Journal:  Nervenarzt       Date:  2012-06       Impact factor: 1.214

2.  Should age be considered when proposing decompressive hemicraniectomy in malignant stroke, and if so where is the limit?

Authors:  Dimitre Staykov; Stefan Schwab
Journal:  Neurocrit Care       Date:  2012-10       Impact factor: 3.210

3.  Open the doors of the ICU to patients with malignancies and neurological complications.

Authors:  Michael Piagnerelli; Benjamin Legros
Journal:  Intensive Care Med       Date:  2009-11-12       Impact factor: 17.440

4.  Severe leukoaraiosis portends a poor outcome after traumatic brain injury.

Authors:  Nils Henninger; Saef Izzy; Raphael Carandang; Wiley Hall; Susanne Muehlschlegel
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

5.  Intensive Care Unit Admission for Patients in the INTERACT2 ICH Blood Pressure Treatment Trial: Characteristics, Predictors, and Outcomes.

Authors:  Katja E Wartenberg; Xia Wang; Paula Muñoz-Venturelli; Alejandro A Rabinstein; Pablo M Lavados; Craig S Anderson; Thompson Robinson
Journal:  Neurocrit Care       Date:  2017-06       Impact factor: 3.210

6.  Endovascular cooling and endothelial activation in hemorrhagic stroke patients.

Authors:  Marlene Fischer; Anelia Dietmann; Peter Lackner; Ronny Beer; Raimund Helbok; Bettina Pfausler; Markus Reindl; Erich Schmutzhard; Gregor Broessner
Journal:  Neurocrit Care       Date:  2012-10       Impact factor: 3.210

Review 7.  Immunomodulatory therapies in neurologic critical care.

Authors:  Logan M McDaneld; Jeremy D Fields; Dennis N Bourdette; Anish Bhardwaj
Journal:  Neurocrit Care       Date:  2009-09-23       Impact factor: 3.210

8.  Central neurological complications in critically ill patients with malignancies.

Authors:  Stéphane Legriel; Hélène Marijon; Michael Darmon; Virginie Lemiale; Jean-Pierre Bedos; Benoît Schlemmer; Elie Azoulay
Journal:  Intensive Care Med       Date:  2009-11-12       Impact factor: 17.440

9.  Retrospective agreement and consent to neurocritical care is influenced by functional outcome.

Authors:  Ines C Kiphuth; Martin Köhrmann; Joji B Kuramatsu; Christoph Mauer; Lorenz Breuer; Peter D Schellinger; Stefan Schwab; Hagen B Huttner
Journal:  Crit Care       Date:  2010-07-30       Impact factor: 9.097

10.  Prognosis of patients with primary malignant brain tumors admitted to the intensive care unit: a two-decade experience.

Authors:  Maxens Decavèle; Nicolas Weiss; Isabelle Rivals; Hélène Prodanovic; Ahmed Idbaih; Julien Mayaux; Thomas Similowski; Alexandre Demoule
Journal:  J Neurol       Date:  2017-10-09       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.